Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Executive Summary: Clinical Practice Guidelines on the Management of Resistant Tuberculosis of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) and the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)
Adrian Sanchez-Montalva; José Antonio Caminero; Mª Remedio Guna; Teresa Rodrígo Sanz; Ramón Rabuñal; Joan Pau Millet; José Antonio Gullón-Blanco; Luis Anibarro; Guillermo Perez-Mendoza; Juan Francisco Medina; Verónica González-Galán; Eva Tabernero;
Arch Bronconeumol. 2024;60:759-67
Clinical and Epidemiological Correlates of Low IFN-Gamma Responses in Mitogen Tube of QuantiFERON Assay in Tuberculosis Infection Screening During the COVID-19 Pandemic: A Population-Based Marker of COVID-19 Mortality?
Juan-José Palacios-Gutiérrez; Azucena Rodríguez-Guardado; Miguel Arias-Guillén; Rebeca Alonso-Arias; Sergio Palacios-Penedo; José-María García-García; Milagros Balbín; Dolores Pérez-Hernández; Marta Sandoval-Torrientes; Aurora Torreblanca-Gil; Santiago Melón; Víctor Asensi-Álvarez; Jeremy M. Clain; Patricio Escalante;
Arch Bronconeumol. 2022;58:649-59
Diagnóstico de la infección tuberculosa en pacientes inmunodeprimidos y/o candidatos a terapias biológicas mediante el uso combinado de dos pruebas IGRA: T-SPOT.TB/QuantiFERON TB Gold In-Tube vs. T-SPOT.TB/QuantiFERON TB Gold Plus
Ana Fernández-Blázquez; Pablo Argüelles Menéndez; Christian Sabater-Cabrera; José-María García-García; Víctor Asensi Álvarez; Juan José Palacios Gutiérrez;
Arch Bronconeumol. 2022;58:305-10